Guidance for Jazz Pharmaceuticals, Inc. (JAZZ)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | $18.15 – $19.35 | $19.62 | $4.00B – 4.20B | $4.08B | = Maintained | Details |
| 2023 | $16.90 – $17.86 | $18.00 | $3.68B – 3.88B | $3.76B | = Maintained | Details |
| 2023 | $16.90 – $17.85 | $17.44 | $3.68B – 3.88B | $3.78B | = Maintained | Details |
| 2023 | $18.15 – $19.00 | $18.66 | N/A | N/A | = Maintained | Details |
| 2022 | $16.00 – $17.00 | $17.47 | N/A | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $3.50M – 3.70M | $3.58M | = Maintained | Details |
| 2022 | N/A | N/A | $3.65B | $3.65B |  Raised |
Details |
| 2022 | $16.70 – $17.71 | $17.09 | $3.50B – 3.70B | $3.60B | = Maintained | Details |
| 2021 | $15.65 – $16.86 | $16.78 | $2.55B – 2.70B | $2.56B | = Maintained | Details |
| 2021 | $15.65 – $16.86 | $16.39 | $2.55B – 2.70B | $2.65B | = Maintained | Details |
| 2021 | $13.40 – $14.70 | $14.45 | $3.02B – 3.18B | $3.11B | = Maintained | Details |
| 2020 | N/A | N/A | $2.32B – 2.40B | $2.36B | = Maintained | Details |
| 2020 | N/A | N/A | $2.12B – 2.26B | $2.30B |  Lowered |
Details |
| 2020 | $11.90 – $13.00 | $11.73 | $2.23B – 2.33B | $2.20B | Raised |
Details |
| 2019 | $14.30 – $15.00 | $13.98 | $2.05B – 2.13B | $2.03B | Raised |
Details |
| 2019 | $14.30 – $15.00 | $14.60 | $2.05B – 2.13B | $2.07B | = Maintained | Details |
| 2019 | $15.50 – $16.15 | $15.03 | $2.10M – 2.18M | $2.11M | Raised |
Details |
| 2019 | $14.30 – $15.00 | $14.80 | $2.07M – 2.13M | $2.09M | = Maintained | Details |
| 2018 | $12.75 – $13.25 | $12.78 | $1.88B – 1.93B | $1.89B | = Maintained | Details |
| 2018 | $12.65 – $13.25 | $13.07 | $1.86B – 1.93B | $1.85B | = Maintained | Details |
| 2018 | $12.75 – $13.25 | $13.09 | $1.88M – 1.93M | $1.90M | = Maintained | Details |
| 2018 | $12.75 – $13.25 | $13.11 | $1.86M – 1.90M | $1.92M | = Maintained | Details |
| 2017 | $10.70 – $11.30 | $11.12 | $1.63B – 1.70B | $1.67B | = Maintained | Details |
| 2017 | $10.70 – $11.30 | $11.33 | $1.62B – 1.69B | $1.68B | = Maintained | Details |
| 2017 | $10.70 – $11.20 | $10.90 | $1.60M – 1.65M | $1.64M | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $10.90 – $11.30 | $11.42 | $1.49B – 1.55B | $1.54B | Lowered |
Details |
| 2016 | $11.00 – $11.50 | $11.40 | $1.49B – 1.55B | $1.53B | = Maintained | Details |
| 2016 | $9.90 – $10.30 | $11.14 | $1.49B – 1.53B | $1.52B | = Maintained | Details |
| 2016 | $9.90 – $10.30 | $10.06 | $1.49B – 1.53B | $1.51B | = Maintained | Details |
| 2015 | $9.45 – $9.75 | $9.77 | $1.30B – 1.37B | $1.36B | = Maintained | Details |
| 2015 | $9.45 – $9.75 | $9.67 | $1.31B – 1.37B | $1.36B | = Maintained | Details |
| 2015 | $9.45 – $9.60 | $9.67 | $1.32M – 1.34M | $1.36M | = Maintained | Details |
| 2014 | $8.00 – $8.25 | $8.03 | $1.09B – 1.15B | $1.08B | = Maintained | Details |
| 2014 | $8.00 – $8.25 | $8.20 | $1.10B – 1.16B | $1.13B | = Maintained | Details |
| 2014 | $8.00 – $8.25 | $8.07 | $1.13B – 1.17B | $1.13B | Raised |
Details |
| 2014 | $8.20 – $8.35 | $8.17 | $1.15M – 1.17M | $1.16M | Raised |
Details |
| 2013 | $5.70 – $5.90 | $5.71 | $805.00M – 835.00M | $813.70M | = Maintained | Details |
| 2013 | $6.30 – $6.40 | $6.30 | $867.00M – 877.00M | $872.00M | = Maintained | Details |
| 2013 | $6.10 – $6.30 | $5.87 | $830.00M – 860.00M | $825.50M | Raised |
Details |
| 2012 | $4.65 – $4.75 | $4.78 | $575.00M – 585.00M | N/A | = Maintained | Details |
| 2011 | $2.70 – $2.90 | $2.38 | $232.00M – 245.00M | $224.19M | = Maintained | Details |
| 2011 | $3.45 – $3.50 | $3.44 | N/A | N/A | Raised |
Details |
| 2011 | $3.15 – $3.25 | $3.07 | N/A | N/A | = Maintained | Details |
